Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Centene Corp (NY: CNC )

61.60 -0.42 (-0.68%)
Streaming Delayed Price Updated: 10:21 AM EDT, Oct 21, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Centene Corp

< Previous 1 2 3 4 5 6 7 8 9
...
11 12 Next >
Cigna-Humana Merger Talks Back On With Tables Turned; 2024 Election Is Key
Cigna-Humana merger talks are back on, nearly one year after the first try. The price may be more affordable after CI stock outperformed, while HUM struggled. 
Via Investor's Business Daily
NIO, ASML, And CVS Health Are Among Top 10 Large Cap Losers Last Week (Oct 14-18): Are The Others In Your Portfolio?
10 worst performing stocks last week: NIO -16.35%, KLAC -15.58%, CNC -14.38%, Elevance -14.17%, ASML -13.97%, PDD -13.91%, MOH -12.24%, LRCX -12.12%, ERIE -9.92%, CVS -9.44% 
Via Benzinga
Looking Into Centene's Recent Short Interest
Via Benzinga
UnitedHealth Beats But Reins In Outlook As Costs Rise; UNH Stock Slips
The Dow giant's Optum services unit generated over 50% of operating income. 
Via Investor's Business Daily
Topics Stocks
Exposures US Equities
Here's How Much $100 Invested In Centene 20 Years Ago Would Be Worth Today
Via Benzinga
Looking Into Centene's Recent Short Interest
Via Benzinga
$100 Invested In This Stock 20 Years Ago Would Be Worth $1,600 Today
Via Benzinga
Centene Stock: A Deep Dive Into Analyst Perspectives (17 Ratings)
Via Benzinga
Here's How Much You Would Have Made Owning Centene Stock In The Last 15 Years
Via Benzinga
(CNC) - Analyzing Centene's Short Interest
Via Benzinga
Indications Suggest NYSE:CNC Could Be on the Verge of a Breakout.
Technical Insights for CENTENE CORP (NYSE:CNC): Is a Breakout Imminent? 
Via Chartmill
Expert Ratings For Centene
Via Benzinga
In a market where value is scarce, NYSE:CNC offers a refreshing opportunity with its solid fundamentals.
For those who appreciate value investing, CENTENE CORP (NYSE:CNC) is a compelling option with its solid fundamentals. 
Via Chartmill
If You Invested $1000 In This Stock 15 Years Ago, You Would Have $17,000 Today
Via Benzinga
Demystifying Centene: Insights From 13 Analyst Reviews
Via Benzinga
If You Invested $1000 In This Stock 20 Years Ago, You Would Have $13,000 Today
Via Benzinga
The Latest Analyst Ratings For Centene
Via Benzinga
$1000 Invested In This Stock 10 Years Ago Would Be Worth $3,400 Today
Via Benzinga
Wall Street Enjoys Late-Week Rally On Benign Inflation Data, Dow Jones Eyes Best Session Of 2024, Tech Unwinding Stalls: What's Driving Markets Friday?
After a turbulent week in the markets, the bulls reclaimed dominance on Wall Street during Friday’s session, with indices and sectors trading in positive territory as investors welcomed the latest... 
Via Benzinga
Topics Economy Stocks
Exposures Interest Rates US Equities
Centene (CNC) Q2 2024 Earnings Call Transcript
CNC earnings call for the period ending June 30, 2024. 
Via The Motley Fool
Topics Earnings
Exposures Financial
Norfolk Southern Posts Upbeat Earnings, Joins Newell Brands, Charter Communications, 3M And Other Big Stocks Moving Higher On Friday
Via Benzinga
How Is The Market Feeling About Centene?
Via Benzinga
Why Saia Shares Are Trading Lower? Here Are Other Stocks Moving In Friday's Mid-Day Session
Via Benzinga
CNC Stock Earnings: Centene Beats EPS, Beats Revenue for Q2 2024
CNC stock results show that Centene beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024. 
Via InvestorPlace
Navigating 11 Analyst Ratings For Centene
Via Benzinga
Health Insurer Centene's Q2 Premium Revenue Cushions Fall In Medicaid Enrollment, Raises Annual Outlook
Centene reported a 5.9% year-over-year increase in second-quarter sales to $39.84 billion, beating the $36.46 billion consensus. Adjusted EPS rose to $2.42, surpassing the $2.07 consensus. Membership... 
Via Benzinga
If You Can Only Buy One S&P 500 Stock in July, It Better Be One of These 3 Names
It’s getting harder to find S&P 500 stocks that aren’t overvalued, but these three names come to mind to buy in July. 
Via InvestorPlace
Topics Stocks
Exposures US Equities
BofA Downgrades Elevance Health On Medicaid Pressure And Lowered Peer Valuations
Elevance Health reports Q2 revenues of $43.2 billion, slightly above consensus despite a 0.4% YoY decline driven by Medicaid membership attrition. Analysts express concerns over ongoing Medicaid margin... 
Via Benzinga
Duo Health Partners with Arizona Complete Health on Value-Based Care Program to Improve Outcomes for Members with Chronic Kidney Disease and End-Stage Kidney Disease
From Duo Health
Via Business Wire
Rising Trump Election Odds Divide Health Care; HCA Falls, UNH Rises With Earnings Due
UnitedHealth Group stock rose, while HCA Healthcare fell amid higher odds that former President Donald Trump will win the election. UNH earnings are due Tuesday. 
Via Investor's Business Daily
Topics Government
Exposures Political
< Previous 1 2 3 4 5 6 7 8 9
...
11 12 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.